5 results match your criteria: "Centre hospitalier universitaire de Québec (Quebec University Hospital Centre)[Affiliation]"

Article Synopsis
  • - Vaccine effectiveness (VE) against influenza B in Canada was analyzed over 8 seasons, focusing on the Victoria and Yamagata lineages when using the trivalent influenza vaccine.
  • - The VE was found to be 50% or higher in most cases, regardless of whether there was a match between the vaccine strain and the circulating viruses.
  • - The only exception to this high effectiveness occurred when the vaccine strain remained the same as the previous season.
View Article and Find Full Text PDF

Using a test-negative design, the Canadian Sentinel Practitioner Surveillance Network (SPSN) assessed interim 2016/17 influenza vaccine effectiveness (VE) against dominant influenza A(H3N2) viruses considered antigenically matched to the clade 3C.2a vaccine strain. Sequence analysis revealed substantial heterogeneity in emerging 3C.

View Article and Find Full Text PDF

During spring-summer 2009, several observational studies from Canada showed increased risk of medically-attended, laboratory-confirmed A(H1N1)pdm09 illness among prior recipients of 2008-09 trivalent inactivated influenza vaccine (TIV). Explanatory hypotheses included direct and indirect vaccine effects. In a randomized placebo-controlled ferret study, we tested whether prior receipt of 2008-09 TIV may have directly influenced A(H1N1)pdm09 illness.

View Article and Find Full Text PDF

Extra-deep guide-catheter intubation for direct thromboaspiration.

Int J Cardiol

October 2013

Interventional Cardiology Laboratory, Quebec University Hospital Centre (Centre Hospitalier Universitaire de Québec, CHUQ), Laval University, Pavillon Hôtel Dieu de Québec, Quebec, Canada. Electronic address:

View Article and Find Full Text PDF